Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

7.54  -0.17 (-2.2%)

After market: 7.6099 +0.07 (+0.93%)

Fundamental Rating

2

Overall BLMN gets a fundamental rating of 2 out of 10. We evaluated BLMN against 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BLMN have multiple concerns. BLMN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
In the past year BLMN had a positive cash flow from operations.
In multiple years BLMN reported negative net income over the last 5 years.
BLMN had a positive operating cash flow in each of the past 5 years.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a Return On Assets value of -3.78%, BLMN is not doing good in the industry: 75.56% of the companies in the same industry are doing better.
The Return On Equity of BLMN (-94.47%) is worse than 65.93% of its industry peers.
The Return On Invested Capital of BLMN (6.66%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BLMN is below the industry average of 14.13%.
Industry RankSector Rank
ROA -3.78%
ROE -94.47%
ROIC 6.66%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

Looking at the Operating Margin, with a value of 5.19%, BLMN is doing worse than 65.19% of the companies in the same industry.
BLMN's Operating Margin has improved in the last couple of years.
The Gross Margin of BLMN (70.94%) is better than 85.19% of its industry peers.
BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.19%
PM (TTM) N/A
GM 70.94%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BLMN is still creating some value.
The number of shares outstanding for BLMN has been reduced compared to 1 year ago.
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
BLMN has a worse debt/assets ratio than last year.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BLMN has an Altman-Z score of 0.88. This is a bad value and indicates that BLMN is not financially healthy and even has some risk of bankruptcy.
BLMN's Altman-Z score of 0.88 is on the low side compared to the rest of the industry. BLMN is outperformed by 70.37% of its industry peers.
BLMN has a debt to FCF ratio of 140.42. This is a negative value and a sign of low solvency as BLMN would need 140.42 years to pay back of all of its debts.
The Debt to FCF ratio of BLMN (140.42) is worse than 65.93% of its industry peers.
A Debt/Equity ratio of 7.64 is on the high side and indicates that BLMN has dependencies on debt financing.
BLMN's Debt to Equity ratio of 7.64 is on the low side compared to the rest of the industry. BLMN is outperformed by 63.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.64
Debt/FCF 140.42
Altman-Z 0.88
ROIC/WACC0.75
WACC8.86%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.34 indicates that BLMN may have some problems paying its short term obligations.
BLMN's Current ratio of 0.34 is on the low side compared to the rest of the industry. BLMN is outperformed by 82.22% of its industry peers.
BLMN has a Quick Ratio of 0.34. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BLMN (0.26) is worse than 87.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.26
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

BLMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.74%.
The Earnings Per Share has been growing slightly by 3.30% on average over the past years.
Looking at the last year, BLMN shows a very negative growth in Revenue. The Revenue has decreased by -17.68% in the last year.
The Revenue has been decreasing by -0.93% on average over the past years.
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%

3.2 Future

Based on estimates for the next years, BLMN will show a decrease in Earnings Per Share. The EPS will decrease by -5.02% on average per year.
The Revenue is expected to decrease by -2.74% on average over the next years.
EPS Next Y-30.46%
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%
EPS Next 5YN/A
Revenue Next Year-11.48%
Revenue Next 2Y-5.13%
Revenue Next 3Y-2.74%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

6

4. Valuation

4.1 Price/Earnings Ratio

BLMN is valuated cheaply with a Price/Earnings ratio of 4.46.
BLMN's Price/Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 98.52% of the companies in the same industry.
BLMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.82.
BLMN is valuated cheaply with a Price/Forward Earnings ratio of 5.57.
BLMN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 97.04% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BLMN to the average of the S&P500 Index (21.76), we can say BLMN is valued rather cheaply.
Industry RankSector Rank
PE 4.46
Fwd PE 5.57
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLMN is valued cheaper than 97.04% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLMN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 86.73
EV/EBITDA 4.23
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

BLMN's earnings are expected to decrease with -5.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.35
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.87%, BLMN is a good candidate for dividend investing.
In the last 3 months the price of BLMN has falen by -36.32%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 3.73. BLMN pays more dividend than 96.30% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.87%

5.2 History

On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
BLMN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years1
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-64.5%
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (5/23/2025, 9:16:11 PM)

After market: 7.6099 +0.07 (+0.93%)

7.54

-0.17 (-2.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners107.14%
Inst Owner Change0.6%
Ins Owners1.47%
Ins Owner Change7.09%
Market Cap641.35M
Analysts54.44
Price Target9.99 (32.49%)
Short Float %10.56%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 7.87%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-64.5%
Div Incr Years1
Div Non Decr Years2
Ex-Date05-20 2025-05-20 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.82%
Min EPS beat(2)0.68%
Max EPS beat(2)2.96%
EPS beat(4)2
Avg EPS beat(4)-4.47%
Min EPS beat(4)-13.76%
Max EPS beat(4)2.96%
EPS beat(8)6
Avg EPS beat(8)1.77%
EPS beat(12)10
Avg EPS beat(12)2.87%
EPS beat(16)13
Avg EPS beat(16)11.54%
Revenue beat(2)0
Avg Revenue beat(2)-24.08%
Min Revenue beat(2)-45.88%
Max Revenue beat(2)-2.28%
Revenue beat(4)0
Avg Revenue beat(4)-13.22%
Min Revenue beat(4)-45.88%
Max Revenue beat(4)-2.1%
Revenue beat(8)1
Avg Revenue beat(8)-7.42%
Revenue beat(12)2
Avg Revenue beat(12)-5.51%
Revenue beat(16)4
Avg Revenue beat(16)-4.27%
PT rev (1m)-16.79%
PT rev (3m)-36.46%
EPS NQ rev (1m)-2.57%
EPS NQ rev (3m)-17.2%
EPS NY rev (1m)-4.38%
EPS NY rev (3m)-30.82%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)-6.32%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)-6.52%
Valuation
Industry RankSector Rank
PE 4.46
Fwd PE 5.57
P/S 0.16
P/FCF 86.73
P/OCF 2.81
P/B 4.73
P/tB N/A
EV/EBITDA 4.23
EPS(TTM)1.69
EY22.41%
EPS(NY)1.35
Fwd EY17.94%
FCF(TTM)0.09
FCFY1.15%
OCF(TTM)2.68
OCFY35.57%
SpS46.44
BVpS1.59
TBVpS-5.96
PEG (NY)N/A
PEG (5Y)1.35
Profitability
Industry RankSector Rank
ROA -3.78%
ROE -94.47%
ROCE 8.42%
ROIC 6.66%
ROICexc 6.85%
ROICexgc 9.41%
OM 5.19%
PM (TTM) N/A
GM 70.94%
FCFM 0.19%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexcg growth 3Y-22.65%
ROICexcg growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score4
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 7.64
Debt/FCF 140.42
Debt/EBITDA 2.72
Cap/Depr 125.72%
Cap/Sales 5.59%
Interest Coverage 3.42
Cash Conversion 59.96%
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.26
Altman-Z 0.88
F-Score4
WACC8.86%
ROIC/WACC0.75
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
EPS Next Y-30.46%
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%
Revenue Next Year-11.48%
Revenue Next 2Y-5.13%
Revenue Next 3Y-2.74%
Revenue Next 5YN/A
EBIT growth 1Y-43.79%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year32.37%
EBIT Next 3Y11.73%
EBIT Next 5YN/A
FCF growth 1Y-96.45%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-57.15%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%